Several hundred units of counterfeit Ozempic (semaglutide 1mg injection) were seized by the Food and Drug Administration.

Mavacamten was not found to benefit patients with symptomatic NYHA class II-III nonobstructive hypertrophic cardiomyopathy.

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy.

For patients with posterior circulation stroke, alteplase administered at 4.5 to 24 hours after onset increases frequency of functional independence.

Over the past 2 decades, stroke-related mortality among individuals with HIV has decreased, but racial and gender disparities continue to exist.

Engaging in physical activity concentrated within 1 to 2 days is associated with a similar reduction in mortality risk as active regular physical activity.

A study has found that moderate-to-severe obstructive sleep apnea increases risk for incident myocardial infarction between 12 and 5:59 AM.

Patients that use noncigarette tobacco products may have elevated subclinical markers related to inflammation, thrombosis, and atherosclerosis.

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

Maternal obesity had a strong influence on offspring obesity/severe obesity, and maternal smoking had a significant effect on all 3 outcomes.

There are substantial rural-urban disparities in cardiometabolic risk factors and cardiovascular diseases among US adults.

Federal cuts to funding could “decimate” medical research in the US, delaying cures and costing countless lives.